1-methylpyridinium
RN given refers to parent cpd
Also Known As:
1-methylpyridinium chloride; 1-methylpyridinium dibromoiodate (1-); 1-methylpyridinium iodide; 1-methylpyridinium mu-iodotetraiododimercurate (1-); N-methylpyridinium
Networked: 10
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Crapo, James D:
1 article
(11/2021)
|
2. | Curran-Everett, Douglas:
1 article
(11/2021)
|
3. | Kallet, Julia:
1 article
(11/2021)
|
4. | Lindsay, Hunter G:
1 article
(11/2021)
|
5. | Lindsay, Sarah E:
1 article
(11/2021)
|
6. | Regan, Elizabeth A:
1 article
(11/2021)
|
7. | Weaver, Michael R:
1 article
(11/2021)
|
8. | Calabriso, Nadia:
1 article
(10/2021)
|
9. | Carluccio, Maria Annunziata:
1 article
(10/2021)
|
10. | Damiano, Fabrizio:
1 article
(10/2021)
|
Related Diseases
1. | Neoplasms (Cancer)
|
2. | Overweight
|
3. | Parkinsonian Disorders (Parkinsonism)
|
4. | Onychomycosis (Tinea Unguium)
01/01/2014
- " Novel multifunctional photosensitizers (MFPSs), 5,10,15-tris(4-N-methylpyridinium)-20-(4-phenylthio)-[21H,23H]-porphine trichloride (PORTH) and 5,10,15-tris(4-N-methylpyridinium)-20-(4-(butyramido-methylcysteinyl)-hydroxyphenyl)-[21H,23H]-porphine trichloride (PORTHE), derived from 5,10,15-Tris(4-methylpyridinium)-20-phenyl-[21H,23H]-porphine trichloride (Sylsens B) and designed for treatment of onychomycosis were characterized and their functionality evaluated. "
|
5. | Polyps
|
|
Related Drugs and Biologics